Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet ROUVAX V.ruj. min. 10CCID 50 lyophilized and solvent
- Product code:
- W13337003
- Quantity:
- 10
- Indicated for:
- prevention of measles, mumps and rubella
- Route of administration:
- injectable
- Substance:
- live attenuated measles vaccine (vaccine)
- ATC
- J07BD01 — Antiinfectives for systemic use | Viral vaccines | Measles vaccines
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Avoid live vaccines
Avoid live vaccines during treatment if contraindicated.
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.
The live attenuated measles vaccine is used to prevent measles, a highly contagious viral disease caused by the measles virus. The vaccine contains a weakened form of the virus, which stimulates the immune system to produce specific antibodies against it, providing long-term protection against infection.
The vaccine is administered subcutaneously, usually in two doses, with the first dose given at 12-15 months of age and the second between 4 and 6 years. It is recommended for children and adults who have not been previously vaccinated or have not had measles.
Common side effects include fever, rashes, pain, or swelling at the injection site. In rare cases, severe adverse reactions such as febrile seizures or allergic reactions may occur.
The live attenuated measles vaccine is an essential preventive measure for reducing the incidence of measles and its associated complications, such as encephalitis or viral pneumonia.
The vaccine is administered subcutaneously, usually in two doses, with the first dose given at 12-15 months of age and the second between 4 and 6 years. It is recommended for children and adults who have not been previously vaccinated or have not had measles.
Common side effects include fever, rashes, pain, or swelling at the injection site. In rare cases, severe adverse reactions such as febrile seizures or allergic reactions may occur.
The live attenuated measles vaccine is an essential preventive measure for reducing the incidence of measles and its associated complications, such as encephalitis or viral pneumonia.
General data about ROUVAX V.ruj. min. 10CCID 50
- Substance:
- live attenuated measles vaccine
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W13337003
- Concentration:
- V.ruj. min. 10CCID 50
- Pharmaceutical form:
- lyophilized and solvent
- Quantity:
- 10
- Product type:
- Generic medicine
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for live attenuated measles vaccine
Concentrations available for live attenuated measles vaccine
- min. 1000 DICC50/0.5ml
- V.ruj. min. 10CCID 50